A Case of Olanzapine-Induced Gestational Diabetes Mellitus in the Absence of Weight Gain
J Clin Psychiatry 2007;68(12):1989-1989 [letter]
© Copyright 2015 Physicians Postgraduate Press, Inc.
Purchase This PDF for $40.00
If you are not a paid subscriber, you may purchase the PDF.
(You'll need the free Adobe Acrobat Reader.)
Receive immediate full-text access to JCP. You can subscribe to JCP online-only ($86) or print + online ($156 individual).
With your subscription, receive a free PDF collection of the NCDEU Festschrift articles. Hurry! This offer ends December 31, 2011.
If you are a paid subscriber to JCP and do not yet have a username and password, activate your subscription now.
As a paid subscriber who has activated your subscription, you have access to the HTML and PDF versions of this item.
Click here to login.
Did you forget your password?
Still can't log in? Contact the Circulation Department at 1-800-489-1001 x4 or send email
Because this piece does not have an abstract, we have provided for your benefit the first 3 sentences of the full text.
Sir: Second-generation antipsychotics have been implicated in the development of obesity, diabetes mellitus, and insulin resistance. Pregnancy increases the risk for insulin resistance, sometimes resulting in gestational diabetes mellitus. We describe a case of a woman with bipolar disorder who developed gestational diabetes in the absence of significant weight gain while treated with olanzapine during 2 pregnancies.